Search results for N-terminal

Protein N-Terminal Asparagine Amidohydrolase (NTAN1) Antibody, Abbexa, abx029762

Side-chain deamidation of N-terminal asparagine residues to aspartate. Required for the ubiquitin-dependent turnover of intracellular proteins that initiate with Met-Asn. These proteins are acetylated on the retained initiator methionine and can subsequently be modified by the removal of N-acetyl methionine by acylaminoacid hydrolase (AAH). Conversion of the resulting N-terminal asparagine to aspartate by PNAD renders the protein susceptible to arginylation, polyubiquitination and degradation as specified by the N-end rule. This enzyme does not act on substrates with internal or C-terminal asparagines and does not act on glutamine residues in any position (By similarity).

USP6 N-Terminal Like Protein (USP6NL) Antibody, Abbexa, abx322907

USP6NL Antibody is a Rabbit Polyclonal against USP6NL.

Anti-ATE1 antibody [EPR13667(2)] - N-terminal, Abcam, AB199423

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-ATP7b antibody [S62-29] - N-terminal, Abcam, AB240880

Anti-Avian Influenza A Neuraminidase antibody - N-terminal, Abcam, AB191862

CTTNBP2 N-Terminal-Like Protein (CTTNBP2NL) Antibody, Abbexa, abx232069

CTTNBP2NL Antibody is a Rabbit Polyclonal against CTTNBP2NL.

STARD3 N-Terminal-Like Protein (STARD3NL) Antibody, Abbexa, abx115838

Stard3 N-Terminal Like Antibody is a Rabbit Polyclonal antibody against Stard3 N-Terminal Like.

PE Anti-Raf1 antibody [EP4969] - N-terminal, Abcam, AB310911

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

PE Anti-SLC34A2 antibody [SP322] - N-terminal, Abcam, AB322453

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

USP6 N-Terminal Like Protein (USP6NL) Antibody, Abbexa, abx175049

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product. USP6 N-Terminal Like Protein (USP6NL) Antibody is a Mouse Monoclonal antibody against USP6 N-Terminal Like Protein (USP6NL).